Phase
Condition
Infertility
Treatment
Density grade centrifugation
Microfluidic sperm separation device
Clinical Study ID
Ages 18-41 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Undergoing first IVF cycle
Electing single embryo transfer
Electing PGT-A of their embryos
Female partners age <42 years old at start of VOR cycle, but >18 years old.
AMH ≥ 1.2 ng/mL
AFC ≥ 8
FSH ≤ 12IU/L
At least 4 mature oocytes (M2s) retrieved at the VOR procedure in order to randomize
Intention to transfer the morphological best quality, euploid, embryo at the frozenembryo transfer procedure
Exclusion
Exclusion Criteria:
Contraindication to IVF
Clinical indication for preimplantation genetic testing (i.e., screening for singlegene disorder, chromosomal translocation, or any other disorders requiring a moredetailed embryo genetic analysis)
Male partner with azoospermia or oligozoospermia (<500,000 total motile spermatozoaon the most recent semen analysis within one year of enrollment)
Planned for previously cryopreserved sperm to be used for ICSI
Donor sperm
Male partner with Y-chromosome microdeletion
Male partner with any Karyotype other than 46,XY
Male partner requiring surgically obtained sperm either via testicular or epididymalretrieval procedures
Uncorrected hydrosalpinges that communicate with the endometrial cavity
Endometrial Insufficiency, as defined by a prior cycle with maximal endometrialthickness <6mm,), or persistent endometrial fluid
Donor oocyte or embryo cycles
Gestational carriers
Study Design
Study Description
Connect with a study center
Reproductive Medicine Associates of New Jersey
Basking Ridge, New Jersey 07920
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.